India Entry Strategy for International Companies
Entering the Indian market requires navigating a complex web of regulatory requirements, business registration processes, and compliance frameworks that vary by product category. India’s regulatory landscape spans 15+ regulatory bodies — from CDSCO and FSSAI to BIS, DGFT, and WPC — each with its own approval processes, timelines, and documentation requirements.
ACPL provides comprehensive India market entry strategy services to international companies across pharmaceuticals, medical devices, food products, cosmetics, agrochemicals, and consumer electronics. With 25+ years of experience and 1,150+ clients served, we have guided hundreds of international companies from initial market assessment through to successful product launch in India.
What We Offer
- Regulatory landscape assessment and gap analysis
- Market entry pathway strategy — identifying optimal registration routes and timelines
- Indian Authorized Agent (IAA) representation for CDSCO, BIS, and WPC
- Product registration and licensing roadmap across all applicable regulators
- Entity setup advisory — subsidiary, liaison office, branch office, or partnership structures
- Local partner identification, evaluation, and due diligence
- Ongoing regulatory compliance management and maintenance
- Post-market surveillance and vigilance system setup
Industry-Specific Entry Strategies
Each industry faces unique regulatory requirements in India:
- Pharmaceuticals — CDSCO registration, clinical trial approvals, NPPA pricing, pharmacovigilance
- Medical Devices — CDSCO device registration, BIS certification, materiovigilance
- Food & Nutraceuticals — FSSAI licensing, legal metrology, food safety vigilance
- Cosmetics — CDSCO cosmetic registration, cosmetovigilance
- Electronics & IoT — BIS CRS, WPC ETA, EPR registration
- Agrochemicals — CIB&RC registration, field safety trials
Why ACPL for India Entry
- 25+ years navigating Indian regulatory frameworks
- 1,150+ clients including multinationals like Reckitt, BD, Johnson & Johnson, and Eli Lilly
- 2,700+ projects across every major product category
- Single-window service — One partner for all regulatory requirements instead of juggling multiple consultants
- Top 10 recognition — Named among Asia’s Top 10 Most Promising Regulatory Consultants (2023)
Typical India Entry Timeline
- Assessment (2–4 weeks) — Regulatory landscape mapping, product classification, pathway identification
- Strategy & Documentation (4–8 weeks) — Dossier preparation, application filing, agent appointment
- Regulatory Review (3–12 months) — Timeline varies by product category and regulatory body
- Approval & Launch (2–4 weeks) — License issuance, import logistics, market launch support